NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells
Open Access
- 10 November 2014
- journal article
- clinical trial
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 124 (12), 5453-5465
- https://doi.org/10.1172/jci76611
Abstract
High aldehyde dehydrogenase (ALDH) activity is a marker commonly used to isolate stem cells, particularly breast cancer stem cells (CSCs). Here, we determined that ALDH1A1 activity is inhibited by acetylation of lysine 353 (K353) and that acetyltransferase P300/CBP–associated factor (PCAF) and deacetylase sirtuin 2 (SIRT2) are responsible for regulating the acetylation state of ALDH1A1 K353. Evaluation of breast carcinoma tissues from patients revealed that cells with high ALDH1 activity have low ALDH1A1 acetylation and are capable of self-renewal. Acetylation of ALDH1A1 inhibited both the stem cell population and self-renewal properties in breast cancer. Moreover, NOTCH signaling activated ALDH1A1 through the induction of SIRT2, leading to ALDH1A1 deacetylation and enzymatic activation to promote breast CSCs. In breast cancer xenograft models, replacement of endogenous ALDH1A1 with an acetylation mimetic mutant inhibited tumorigenesis and tumor growth. Together, the results from our study reveal a function and mechanism of ALDH1A1 acetylation in regulating breast CSCs.This publication has 41 references indexed in Scilit:
- Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapyLaboratory Investigation, 2011
- SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C ActivityCancer Cell, 2011
- Ptpn11/Shp2 Acts as a Tumor Suppressor in Hepatocellular CarcinogenesisCancer Cell, 2011
- Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch4 ReceptorCancer Research, 2010
- A Method for Genetically Installing Site-Specific Acetylation in Recombinant Histones Defines the Effects of H3 K56 AcetylationMolecular Cell, 2009
- High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic abilityJournal of Cellular and Molecular Medicine, 2008
- ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical OutcomeCell Stem Cell, 2007
- Retinaldehyde represses adipogenesis and diet-induced obesityNature Medicine, 2007
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003
- Notch Signaling: Cell Fate Control and Signal Integration in DevelopmentScience, 1999